Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation THT 2025

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Presenter: Jacob Abraham

February 12, 2025

Presentation THT 2025

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Presenter: Miguel Woodham

February 12, 2025

Presentation THT 2025

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Presenter: Kanika Mody

February 12, 2025

Presentation THT 2025

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Presenter: Katherine Wood

February 12, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT 2025

Impella 5.5: A GameChanger for Cardiogenic Shock

Presenter: Jerome Crowley

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2024

Early Experience With IMPELLA RP Flex

Presenter: Kanika P. Mody

March 04, 2024

Presentation THT 2024

Achieving Heart Recovery in HF with Cardiogenic Shock

Presenter: Debbie Rinde-Hoffman

March 04, 2024

Presentation THT 2024

Healing Hearts: Achieving Native Heart Recovery

Presenter: Scott Silvestry

March 04, 2024

Presentation THT 2023

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Presenter: Muath Bishawi

March 21, 2023

Presentation THT 2023

Impella as a Bridge-to-Closure in Post-Infarction Ventricular Septal Defect

Presenter: Sandeep Jalli

March 21, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Advertisement

Impella 5.5 Support for Heart Failure-Related Cardiogenic Shock and 1-Year Survival: Insights From a Multi-Center Registry

Handheld Ultrasound Reliably Measures Placement of Impella® Devices

Introduction of Guideline Directed Medical Therapy (GDMT) in Acute Myocardial Infarction (AMI) Shock Patients Supported by Impella 5.5

Debate: Impella 5.5 Should Be Used to Optimize PTs Pre LVAD

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Impella 5.5: A GameChanger for Cardiogenic Shock

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Early Experience With IMPELLA RP Flex

Achieving Heart Recovery in HF with Cardiogenic Shock

Healing Hearts: Achieving Native Heart Recovery

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Impella as a Bridge-to-Closure in Post-Infarction Ventricular Septal Defect

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content